Abstract:The prevalence of diabetes has been accelerating at an alarming rate in the last decade; some describe it as an epidemic. Diabetic eye complications are the leading cause of blindness in adults aged 25-74 in the United States. Early diagnosis and development of effective preventatives and treatments of diabetic retinopathy are essential to save sight. We describe efforts to establish functional indicators of retinal health and predictors of diabetic retinopathy. These indicators and predictors will be needed as markers of the efficacy of new therapies. Clinical trials aimed at either prevention or early treatments will rely heavily on the discovery of sensitive methods to identify patients and retinal locations at risk, as well as to evaluate treatment effects. We report on recent success in revealing local functional changes of the retina with the multifocal electroretinogram (mfERG). This objective measure allows the simultaneous recording of responses from over 100 small retinal patches across the central 45 degrees field. We describe the sensitivity of mfERG implicit time measurement for revealing functional alterations of the retina in diabetes, the local correspondence between functional (mfERG) and structural (vascular) abnormalities in eyes with early nonproliferative retinopathy, and longitudinal studies to formulate models to predict the retinal sites of future retinopathic signs. A multivariate model including mfERG implicit time delays and 'person' risk factors achieved 86% sensitivity and 84% specificity for prediction of new retinopathy development over one year at specific locations in eyes with some retinopathy at baseline. A preliminary test of the model yielded very positive results. This model appears to be the first to predict, quantitatively, the retinal locations of new nonproliferative diabetic retinopathy development over a one-year period. In a separate study, the predictive power of a model was assessed over one- and two-year follow-ups. This permitted successful prediction of new retinopathy development in eyes with and without retinopathy at baseline. Finally, we briefly describe our current research efforts to (a) locally predict future sight-threatening diabetic macular edema, (b) investigate local retinal function change in adolescent patients with diabetes, and (c) better understand the physiological bases of the mfERG delays. The ability to predict the retinal locations of future retinopathy based on mfERG implicit time provides clinicians a powerful tool to screen, follow-up, and even consider early prophylactic treatment of the retinal tissue in diabetic patients. It also aids identification of 'at risk' populations for clinical trials of candidate therapies, which may greatly reduce their cost by decreasing the size of the needed sample and the duration of the trial.

Reproducibility of Fixed-luminance and Multi-luminance Flicker Electroretinography in Patients With Diabetic Retinopathy Using an Office-based Testing Paradigm

Repeatability and Reproducibility of Retinal Fractal Dimension Measured with Swept-Source Optical Coherence Tomography Angiography in Healthy Eyes: A Proof-of-Concept Study

Mydriasis-Free Flicker Electroretinograms in 204 Healthy Children Aged 0–18 Years: Reference Data From Two Cohorts

Retinal Function in Normal and Diabetic Eyes Mapped with the Slow Flash Multifocal Electroretinogram.

Association Between Multifocal ERG Implicit Time Delays and Adaptation in Patients with Diabetes.

Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device

New Mydriasis-Free Electroretinogram Recorded with Skin Electrodes in Healthy Subjects

The Effects of Diabetic Retinopathy Stage and Light Flicker on Inner Retinal Oxygen Extraction Fraction

Evaluation of light- and dark-adapted ERGs using a mydriasis-free, portable system: clinical classifications and normative data

Retinal Vasculature–function Correlation in Non-Proliferative Diabetic Retinopathy

Multifocal Electroretinogram and Short-Wavelength Automated Perimetry Measures in Diabetic Eyes with Little or No Retinopathy.

Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device

Prognostic Value of Multifocal Electroretinography and Optical Coherence Tomography in Eyes Undergoing Panretinal Photocoagulation for Diabetic Retinopathy.

Electrophysiological findings in long-term type 1 diabetes patients without diabetic retinopathy using different ERG recording systems

Cone Photoreceptor Dysfunction in Early-Stage Diabetic Retinopathy: Association Between the Activation Phase of Cone Phototransduction and the Flicker Electroretinogram

Compare Wide-field Swept-Source Optical Coherence Tomography Angiography with Ultra-wide Field Color Fundus Photo and Fluorescein Angiography for Detecting Diabetic Retinopathy …

Evaluation of optical coherence tomography angiography and pattern and flash electroretinography in diabetes mellitus without retinopathy

A multifocal electroretinogram model predicting the development of diabetic retinopathy.

Quantitative Biomarkers of Diabetic Retinopathy Using Ultra-Widefield Fluorescein Angiography

Comparison of Neovascularization Detection in Proliferative Diabetic Retinopathy Using Widefield Swept-Source Optical Coherence Tomography Angiography and Fluorescein Angiography among Ophthalmology Residents at a Single Institution

Flicker electroretinogram in preterm infants